Delivery Order SPE2DB24D2003-SPE2DB25FXLR5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,559.33 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RYTARY ER 36.25 mg–145 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,565.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The delivery order is issued under a firm fixed-price contract with an ultimate completion date of July 21, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award includes no set-aside designation and was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $35.4K to AmerisourceBergen Drug Corp for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count units). This contract, executed on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order was competitively awarded and falls...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,956.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of RYTARY ER 23.75 mg-95 mg capsules (100-count units). The order, which represents no set-aside designation and is due for completion by August 11, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,796.99 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg-195 mg capsules (100-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and was awarded on July 24, 2025, without any set-aside designation. The award was executed through open competition, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements. Performance...
- The Defense Logistics Agency awarded a $11,176.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of RYTARY ER 23.75 MG-95 MG, a pharmaceutical product used in the treatment of Parkinson's disease. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $6,963.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count containers). This is a non-set-aside competitive award with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Rytary is a combination levodopa/carbidopa extended-release medication used to treat...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,025.48 on August 5, 2025, for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count). The contract, which is non-set-aside and competitively awarded, utilizes firm fixed pricing and is scheduled for completion by August 6, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,919.30, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used to treat Parkinson's disease. The contract is a firm-fixed-price delivery order, with an ultimate completion date of April 22, 2025. It is not designated as a set-aside contract, indicating open competition....
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLR5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,670.46 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg-195 mg capsules (100-count supply) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen Drug Corp's comprehensive IDC that supports military and federal healthcare systems globally. RYTARY, a combination carbidopa/levodopa extended-release medication used in Parkinson's disease treatment, exemplifies the specialized pharmaceutical products the contractor supplies to support Defense Health Agency and other government healthcare programs. The transaction reflects the competitive, non-set-aside procurement model through which AmerisourceBergen Drug Corp consistently delivers medical supplies across multiple therapeutic domains to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/13/25 |